1990
DOI: 10.1097/00006454-199003000-00017
|View full text |Cite
|
Sign up to set email alerts
|

Aerosolized Vancomycin for Treatment of Airway Colonization by Methicillin-Resistant Staphylococcus Aureus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0
1

Year Published

1998
1998
2012
2012

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(14 citation statements)
references
References 0 publications
0
13
0
1
Order By: Relevance
“…Despite reports of local pain and soft tissue necrosis due to paravasal injection, different in vivo studies have reported the effectiveness of a local antibiotic therapy using vancomycin, stating a low antigenicity and rare toxic side effects [24][25][26]. Accordingly, experiments performed to investigate the cytotoxicity of vancomycin in cultured human fibroblasts and keratinocytes revealed a high level of tissue tolerance [27].…”
Section: Discussionmentioning
confidence: 99%
“…Despite reports of local pain and soft tissue necrosis due to paravasal injection, different in vivo studies have reported the effectiveness of a local antibiotic therapy using vancomycin, stating a low antigenicity and rare toxic side effects [24][25][26]. Accordingly, experiments performed to investigate the cytotoxicity of vancomycin in cultured human fibroblasts and keratinocytes revealed a high level of tissue tolerance [27].…”
Section: Discussionmentioning
confidence: 99%
“…However, the only available data include a case report of successful treatment for chronic MRSA infection in a 10-year-old CF patient [41] and eradication of MRSA colonization in children with bronchopulmonary dysplasia [42] and in elderly patients [43].…”
Section: Ventilator-associated Pneumoniamentioning
confidence: 99%
“…Inhalation vancomycin is perhaps the best studied of these agents. Case reports and small, nonrandomized, prospective studies have suggested that aerosolized vancomycin can eliminate upper respiratory tract MRSA colonization [22]. The US Centers for Disease Control and Prevention has discouraged the use of vancomycin for this purpose, primarily due to concerns that inadvertently ingested drug could result in the selection of vancomycin-resistant enterococci [37].…”
Section: Nebulized Antibioticsmentioning
confidence: 99%